Company Filing History:
1 out of 78 
1 out of 1 Years Active: 2018
Title: Kristian Klemp: Innovator in Neuropeptide Research
Introduction
Kristian Klemp is a notable inventor based in Charlottenlund, Denmark. He has made significant contributions to the field of neuropeptide research, particularly with his innovative work on neuropeptide Y-derived peptides. His research focuses on the potential therapeutic applications of these peptides in treating various neurological disorders.
Latest Patents
Klemp holds a patent for "Neuropeptide Y-derived peptides." This invention discloses peptide fragments derived from neuropeptide Y (NPY), which are capable of selective binding to the neural cell adhesion molecule (NCAM). These peptides induce neuroplastic and neuroprotective effects, making them valuable as neuritogenic agents for treating pathological conditions where neuroprotection and neuroplastic changes are desired, such as brain and retina disorders. He has 1 patent to his name.
Career Highlights
Throughout his career, Kristian Klemp has worked with esteemed institutions, including the University of Copenhagen and Næstved Hospital. His work in these organizations has allowed him to advance his research and collaborate with other experts in the field.
Collaborations
Klemp has collaborated with notable colleagues, including David Paul D Woldbye and Casper Rene Gøtzsche. These partnerships have contributed to the depth and impact of his research.
Conclusion
Kristian Klemp's innovative work in neuropeptide research highlights his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of neurological disorders.